There is no single “best” weight loss pill for men, but the most effective options by a wide margin are the newer injectable medications: tirzepatide (Zepbound) and semaglutide (Wegovy). In a head-to-head trial, tirzepatide produced an average weight loss of 20.2% of body weight over 72 weeks, while semaglutide produced 13.7%. For a 250-pound man, that translates to roughly 50 pounds versus 34 pounds. Both require a prescription, and eligibility depends on your BMI and overall health profile.
How the Top Medications Compare
The FDA has approved six medications for long-term weight management. They fall into three categories based on how they work, and their results vary dramatically.
Tirzepatide (Zepbound) is the most effective option available. It mimics two gut hormones that regulate appetite, making you feel full sooner and reducing food cravings at the neurological level. In clinical trials, participants lost between 15% and 20.9% of their body weight depending on dose, over about 72 weeks. It’s a once-weekly injection.
Semaglutide (Wegovy) works through one of those same gut hormones. Clinical trial participants lost an average of 14.9% of their body weight over 68 weeks. Also a once-weekly injection. An oral version of semaglutide exists but produces somewhat less weight loss: in real-world comparisons, injectable semaglutide led to roughly 40% greater reductions in weight than the oral form over six months.
Phentermine-topiramate (Qsymia) is the strongest oral pill. It combines an appetite suppressant with a medication that makes you feel satisfied sooner. Average weight loss ranges from 7.8% to 10.9% depending on dose, which puts it well behind the injectables but ahead of other pills. It’s taken daily by mouth.
Naltrexone-bupropion (Contrave) is another daily oral option that reduces hunger through a different brain pathway. It produces more modest results than Qsymia and is sometimes chosen for men who also deal with depression or are quitting smoking, since bupropion treats those conditions independently.
Orlistat (Xenical, or Alli over the counter) is the weakest performer. Instead of targeting appetite, it blocks about 30% of the fat you eat from being absorbed. The tradeoff is significant gastrointestinal side effects: oily spotting affects roughly 27% of users, and fatty stool, fecal urgency, and gas with discharge each affect more than 20%.
Why Men Respond Differently
Weight loss medications aren’t formulated differently for men, but men often see distinct benefits because of how excess weight affects male hormones. Carrying significant extra weight lowers testosterone, which compounds the problem by reducing energy, muscle mass, and motivation to stay active. A meta-analysis of studies on GLP-1 medications (the class that includes both Wegovy and Zepbound) found that treatment significantly increased both total testosterone and bioavailable testosterone in men. That hormonal rebound can improve energy, mood, and body composition beyond what the scale shows.
Men also tend to carry more visceral fat, the deep abdominal fat wrapped around organs. In the head-to-head trial comparing tirzepatide and semaglutide, tirzepatide reduced waist circumference by an average of 18.4 cm (over 7 inches) compared to 13 cm for semaglutide. Waist circumference is a strong proxy for visceral fat loss, which matters because visceral fat drives the metabolic problems linked to heart disease and type 2 diabetes.
The Muscle Mass Tradeoff
One concern that’s especially relevant for men is losing muscle along with fat. With semaglutide, up to 40% of total weight lost may come from lean body mass. Tirzepatide performs better on this front, with about 25% of weight loss coming from lean mass. “Lean body mass” includes water, bone, and organ tissue in addition to muscle, so the actual skeletal muscle loss is likely smaller than those numbers suggest. Still, the difference is real enough to pay attention to.
Resistance training is the most reliable way to offset this. Lifting weights or doing bodyweight exercises while on these medications helps preserve the muscle you have and can even build new tissue, especially if you’re eating adequate protein. If keeping muscle mass is a priority for you, this is not optional, it’s essential to pair with any weight loss medication.
Who Qualifies for a Prescription
You typically need a BMI of 30 or higher to be prescribed weight loss medication. If your BMI is 27 or higher and you have at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea), you also qualify. For reference, a 5’10” man hits a BMI of 30 at about 209 pounds.
Certain health conditions rule out specific medications. Phentermine-containing drugs (including Qsymia) are contraindicated if you have cardiovascular risk factors, because they can raise heart rate and blood pressure. GLP-1 medications like Wegovy and Zepbound should not be used by anyone with a personal or family history of medullary thyroid cancer or a condition called multiple endocrine neoplasia. Your prescriber will screen for these before writing a prescription.
What They Cost
Cost is often the deciding factor. Without insurance, Zepbound ranges from $499 to $1,049 per month depending on your dose, with the starting dose (2.5 mg) available for $349. Wegovy falls in a similar range. These prices apply when purchasing directly from the manufacturer’s pharmacy. Insurance coverage varies widely: some plans cover these medications for obesity, many do not, and prior authorization is common even when coverage exists.
Oral options are generally cheaper. Generic orlistat (Alli) is available over the counter for under $50 per month. Qsymia and Contrave fall between the OTC options and the injectables in price, typically running $100 to $300 per month depending on your pharmacy and whether you use manufacturer coupons.
Oral Pills vs. Injections
If the idea of a weekly injection is a dealbreaker, oral options can still produce meaningful weight loss. Qsymia’s 9 to 11% average body weight reduction is clinically significant and comes with the convenience of a daily pill. The most common side effects are constipation, tingling sensations in the hands or feet, dry mouth, and altered taste. At higher doses, insomnia, dizziness, and blurred vision become more common.
An oral form of semaglutide (currently branded as Rybelsus for diabetes) exists, though it must be taken on an empty stomach with minimal water and produces slightly less weight loss than the injectable version. In real-world data, about 39% of oral semaglutide users achieved at least 5% weight loss at six months, compared to about 55% of those on the injectable form.
Picking the Right Option
If maximum weight loss is the goal and cost isn’t a barrier, tirzepatide (Zepbound) has the strongest evidence. It outperformed semaglutide in a direct comparison, preserves more lean mass, and produces the largest reductions in waist circumference. If Zepbound isn’t accessible due to cost or insurance, semaglutide (Wegovy) is the next strongest choice with extensive safety data behind it.
For men who prefer a pill, Qsymia offers the best oral results. Contrave is a reasonable alternative if you also want support for mood or nicotine cravings. Orlistat is the least effective and hardest to tolerate, but it’s the only option available without a prescription (in its lower-dose Alli form).
All of these medications work best when combined with changes to diet and physical activity. In clinical trials, every group, including placebo, received lifestyle counseling. The drugs amplify results from better habits; they don’t replace them. For men specifically, pairing medication with strength training protects muscle mass, supports the testosterone recovery that comes with fat loss, and improves long-term outcomes after the medication is eventually stopped.